Moderna TX Inc. Deal History & Licensing Activity
Moderna TX Inc. is a large biotech. Over the past three years, Moderna TX Inc. has been involved in 1 licensing and acquisition transaction, with a primary focus on Cell Therapy (1 deal). The company currently has 50 active clinical trials, primarily in Infectious.
Deals (12mo)
0
Active Trials
50
Top Modality
Cell Therapy
Focus Area
Infectious
Moderna TX Inc. Pipeline Focus
Therapeutic areas and modalities where Moderna TX Inc. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Moderna TX Inc. Clinical Pipeline
Moderna TX Inc. has 50 active clinical trials across 7 development phases.
4
Phase 4
6
Unknown
13
Phase 1
6
Phase 1/2
10
Phase 2
1
Phase 2/3
10
Phase 3
See How Your Asset Matches Moderna TX Inc.'s Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Infectious assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Cell Therapy Benchmarks
Upfront, milestone, and royalty benchmarks for cell therapy deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Moderna TX Inc. Licensing & Deal Activity
Moderna TX Inc. is a large biotech company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Moderna TX Inc. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Moderna TX Inc. include Infectious (20 deals and trials), Solid Tumors (9 deals and trials), Hematological Malignancies (3 deals and trials), and CNS Disorders (2 deals and trials). In terms of modality, Moderna TX Inc. has shown particular interest in cell therapy.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Moderna TX Inc. and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Moderna TX Inc.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.